Troponin C (Recombinant)

Added to your cart

Troponin C (Recombinant)

Cart subtotal: £0.00

View cart (0) Checkout

#SKU P723-3


Price excludes shipping costs.
To view our shipping costs click here.

Need to order this product in bulk?

Contact our team of experts to discuss your bulk requirements

Contact our expert team

Product Details

The calcium-sensing component of the Troponin complex is troponin C.The structural C-domain (cCTnC) contains two high affinity calcium-binding sites that are occupied by Ca2+ or Mg2+ under physiologic conditions, creating an open conformation anchored to the rest of the troponin complex.the regulatory N-domain (cNTnC) contains a single low affinity site that is largely unoccupied at resting calcium concentrations. Troponin C can have applications in mixturess of the other Troponin molecules ( I and T) to form stabilised heterodimers and stabilised complexed Troponin.


More information



  • Shipping Information
  • Dry Ice
  • Abbreviations
  • Trop C
  • Specification
  • ˃ 96%
  • Recommended Use
  • Research and further manufacturing
  • Preservatives
  • 0.09% NaN3
  • Buffer
  • 50mM NaH2PO4, pH7.5 containing 150mM NaCl
  • Presentation Matrix
  • liquid frozen in 50mM NaH2PO4, pH7.5 containing 150mM NaCl and 0.09% NaN3
  • Purity/grade
  • >96%
  • Source
  • Expressed in E.coli
  • Molecular weight
  • ~18 kDa
  • Uniprot No.
  • P63316

Technical Documents

Certificates Of Analysis (109.5KB)

Sorry, no results found.

Enter the full lot number and hit enter.

BBI Solutions Brands


The acquisition of DIARECT in June 2020 and their world leading recombinant autoimmune antigen capability immediately enhances BBI’s portfolio and position as a ‘complete’ immunoassay reagent supplier. This further enhances BBI’s position as the world’s largest diagnostics components company with a market leading antigen portfolio.


Maine Biotechnology Services brings 27 years of knowledge, experience, process development, and project management to our customers to ensure the best possible antibodies for any application. As antibody development goals in the biotechnology and pharmaceutical industry have evolved the acquisition of MBS will help BBI further meet and exceed our customers needs.


Signup for our newsletter to receive the latest BBI Solutions updates and special offers in your inbox